BioAtla Investor Presentation Deck
Leadership Team
Jay Short, Ph.D.
Chairman, CEO and Cofounder
STRATAGENE
DIVERSA
HARNESSING THE POWER OF ENZYMES
bicatla
life
technologies
Richard Waldron, M.B.A.
Chief Financial Officer
SYNTHETIC GENOMICS
INTREXON GeneMedicine, Inc. COWEN
Cathy Chang, Ph.D.
Sr. VP, Research & Development
DIVERSA
HARNESSING THE POWER OF ENZYMES
STRATAGENE
AND COMPANY
Philippe Martin, M.S., M.B.A.
Chief of Clinical Dev & Operations
Colame Aventis op Schering-Plough
Celgene
William Boyle, Ph.D.
Sr. Research Fellow
Anaptys Bio AMGEN salk
Where cures begin.
Sheri Lydick
Sr. VP, Commercial Strategy
STRATAGENE
Celgenel Bristol Myers Squibb ALTANA
Monica Sullivan
Sr. VP, Intellectual Property & Contracts
DIVERSA
BARNESSING THE POWER OF ENZYMES
CapalP
senomyx
Eric Sievers, M.D.
Chief Medical Officer
OSeattleGenetics ZYMOGENETICS
A Bristol-Myers Squibb Company
Susie Melody
Sr. VP, Human Resources
Biogen.
BCG
BioAtla| Overview
FRED HUTCH
CURES START HERE
4View entire presentation